Document
commission file number 001
| COMMISSION FILE NUMBER 001-42023 | ||||||
| Delaware | 85-3844872 | |||||
| (State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
|||||
| 730 Broadway Redwood City , CA 94063 | (818) 860-1352 | |||||
| (Address of principal executive offices) (Zip Code) | (Registrant’s telephone number, including area code) |
comparison of results of o
| Comparison of Results of Operations for the Years ended December 31, 2025 and 2024 | |||||||||||||||||||||
| Year Ended December 31, | Change | ||||||||||||||||||||
| 2025 | 2024 | $% | |||||||||||||||||||
| Revenues | 2651 | 1813 | 838 | 46% | |||||||||||||||||
| Cost of revenues | 18033 | 1888 | 16145 | 855% | |||||||||||||||||
| Gross loss | -15382 | -75 | -15307 | 20409% | |||||||||||||||||
| Operating expenses: | |||||||||||||||||||||
| Research and development | 45267 | 24255 | 21012 | 87% | |||||||||||||||||
| General and administrative | 37118 | 10093 | 27025 | 268% | |||||||||||||||||
| Operations | 12101 | 3289 | 8812 | 268% | |||||||||||||||||
| Sales and marketing | 2901 | 577 | 2324 | 403% | |||||||||||||||||
| Total operating expenses | 97387 | 38214 | 59173 | 155% | |||||||||||||||||
| Loss from operations | -112769 | -38289 | -74480 | 195% | |||||||||||||||||
| Other income (expense): | |||||||||||||||||||||
| Interest income | 7271 | 1279 | 5992 | 468% | |||||||||||||||||
| Interest expense | -3 | -1959 | 1956 | (100)% | |||||||||||||||||
| Realized gain on foreign currency translation | 2 | — | 2 | 100% | |||||||||||||||||
| Realized gain on investments | 391 | — | 391 | 100% | |||||||||||||||||
| Change in fair value of derivative liability | — | -222 | 222 | (100)% | |||||||||||||||||
| Other income | 91 | — | 91 | 100% | |||||||||||||||||
| Net loss before income taxes | -105017 | -39191 | -65826 | 168% | |||||||||||||||||
| Benefit from income taxes | 3656 | — | 3656 | 100% | |||||||||||||||||
| Net loss | -101361 | -39191 | -62170 | 159% |
key metrics
| Key Metrics | |||||||||||||||||||||
| Three Months Ended December 31, | Year Ended December 31, | ||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||
| Daily Active Robots | 547 | 57 | 273 | 52 | |||||||||||||||||
| Daily Supply Hours | 6676 | 455 | 3196 | 401 |
cash flows
| Cash Flows | |||||||||||||||
| Year Ended December 31, | |||||||||||||||
| 2025 | 2024 | Change | |||||||||||||
| Net cash (used in) / provided by: | |||||||||||||||
| Operating activities | -80241 | -21542 | -58699 | ||||||||||||
| Investing activities | -197999 | -10318 | -187681 | ||||||||||||
| Financing activities | 261212 | 155120 | 106092 | ||||||||||||
| (Decrease) / increase in cash and cash equivalents | -17028 | 123260 | -140288 |
consolidated balance sheets
| Consolidated Balance Sheets | |||||||||
| Year Ended December 31, | |||||||||
| 2025 | 2024 | ||||||||
| ASSETS | |||||||||
| Current assets: | |||||||||
| Cash and cash equivalents | 106239 | 123266 | |||||||
| Short-term marketable securities | 127170 | — | |||||||
| Accounts receivable, net | 851 | 87 | |||||||
| Inventory | — | 310 | |||||||
| Prepaid expenses | 6042 | 1397 | |||||||
| Other receivables | 696 | 192 | |||||||
| Other current assets | 77 | — | |||||||
| Total current assets | 241075 | 125252 | |||||||
| Property and equipment, net | 47013 | 11963 | |||||||
| Long-term marketable securities | 26344 | — | |||||||
| Intangible assets, net | 31313 | — | |||||||
| Goodwill | 15530 | — | |||||||
| Operating lease right-of-use assets | 5369 | 1808 | |||||||
| Other non-current assets | 1107 | 578 | |||||||
| Total assets | 367751 | 139601 | |||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||
| Current liabilities: | |||||||||
| Accounts payable | 5014 | 4902 | |||||||
| Accrued liabilities | 6482 | 655 | |||||||
| Deferred revenue | 2 | 20 | |||||||
| Operating lease liabilities, current | 1800 | 666 | |||||||
| Financing lease liabilities, current | — | 564 | |||||||
| Total current liabilities | 13298 | 6807 | |||||||
| Operating lease liabilities, non-current | 3454 | 1113 | |||||||
| Deferred tax liabilities | 255 | — | |||||||
| Total liabilities | 17007 | 7920 | |||||||
| Commitments and contingencies (Note 13) | |||||||||
| Stockholders’ equity: | |||||||||
| Preferred stock, $ 0.0001 par value, 10,000,000 shares authorized, no shares issued or outstanding as of both December 31, 2025 and 2024 | — | — | |||||||
| Common stock, $ 0.0001 par value; 300,000,000 shares authorized, 74,781,782 and 51,396,574 shares issued, and 74,734,949 and 51,288,566 shares outstanding as of December 31, 2025 and 2024, respectively | 7 | 5 | |||||||
| Additional paid-in capital | 559485 | 239201 | |||||||
| Accumulated other comprehensive income | 138 | — | |||||||
| Accumulated deficit | -208886 | -107525 | |||||||
| Total stockholders’ equity | 350744 | 131681 | |||||||
| Total liabilities and stockholders’ equity | 367751 | 139601 |
operations and comprehensi
| Consolidated Statements of Operations and Comprehensive Loss | |||||||||
| Year Ended December 31, | |||||||||
| 2025 | 2024 | ||||||||
| Revenues | 2651 | 1813 | |||||||
| Cost of revenues | 18033 | 1888 | |||||||
| Gross loss | -15382 | -75 | |||||||
| Operating expenses: | |||||||||
| Research and development | 45267 | 24255 | |||||||
| General and administrative | 37118 | 10093 | |||||||
| Operations | 12101 | 3289 | |||||||
| Sales and marketing | 2901 | 577 | |||||||
| Total operating expenses | 97387 | 38214 | |||||||
| Loss from operations | -112769 | -38289 | |||||||
| Other income (expense): | |||||||||
| Interest income | 7271 | 1279 | |||||||
| Interest expense | -3 | -1959 | |||||||
| Realized gain on foreign currency translation | 2 | — | |||||||
| Realized gain on investments | 391 | — | |||||||
| Change in fair value of derivative liability | — | -222 | |||||||
| Other income | 91 | — | |||||||
| Net loss before income taxes | -105017 | -39191 | |||||||
| Benefit from income taxes | 3656 | — | |||||||
| Net loss | -101361 | -39191 | |||||||
| Other comprehensive income, net of tax: | |||||||||
| Unrealized gain on investments | 189 | — | |||||||
| Other comprehensive income, before tax | 189 | — | |||||||
| Income tax expense related to items of other comprehensive income | -51 | — | |||||||
| Other comprehensive income, net of tax | 138 | — | |||||||
| Comprehensive loss | -101223 | -39191 | |||||||
| Weighted average common shares outstanding - basic and diluted | 62284449 | 36658834 | |||||||
| Net loss per common share - basic and diluted | -1.63 | -1.07 |
stockholders equity deficit
| Consolidated Statements of Stockholders Equity (Deficit) | ||||||||||||||||||||||||||||||||||||||||||
| Common Stock | Additional Paid-in Capital | Subscription Receivable |
Accumulated Other Comprehensive Income | Accumulated Deficit |
Total Stockholders’ Equity (Deficit) | |||||||||||||||||||||||||||||||||||||
| Shares | Amount | |||||||||||||||||||||||||||||||||||||||||
| Balances at December 31, 2023 | 24508795 | 2 | 64468 | -170 | $— | -68334 | -4034 | |||||||||||||||||||||||||||||||||||
| Issuance of common stock pursuant to offering | 10000000 | 1 | 39999 | — | — | — | 40000 | |||||||||||||||||||||||||||||||||||
| Offering costs | — | — | -4151 | — | — | — | -4151 | |||||||||||||||||||||||||||||||||||
| Conversion of convertible note and derivative liability into common stock | 2104562 | — | 6804 | — | — | — | 6804 | |||||||||||||||||||||||||||||||||||
| Issuance of common stock under the Sales Agreement and Equity Distribution Agreement, net of offering costs | 5698992 | 1 | 77595 | — | — | — | 77596 | |||||||||||||||||||||||||||||||||||
| Restricted stock awards repurchased | -233208 | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
| Interest on recourse loan | — | — | — | 4 | — | — | 4 | |||||||||||||||||||||||||||||||||||
| Interest and forgiveness on recourse loans | — | — | — | 166 | — | — | 166 | |||||||||||||||||||||||||||||||||||
| Issuance of pre-funded warrants to purchase common stock in connection with private placement, net of issuance costs | 3055555 | — | 17116 | — | — | — | 17116 | |||||||||||||||||||||||||||||||||||
| Vested restricted stock units | 377284 | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
| Exercise of warrants | 5264799 | 1 | 22448 | — | — | — | 22449 | |||||||||||||||||||||||||||||||||||
| Exercise of options | 511787 | — | 367 | — | — | — | 367 | |||||||||||||||||||||||||||||||||||
| Stock-based compensation | — | — | 14555 | — | — | — | 14555 | |||||||||||||||||||||||||||||||||||
| Net loss | — | — | — | — | — | -39191 | -39191 | |||||||||||||||||||||||||||||||||||
| Balances at December 31, 2024 | 51288566 | 5 | 239201 | — | — | -107525 | 131681 | |||||||||||||||||||||||||||||||||||
| Issuance of common stock, net of offering costs | 10460525 | 1 | 170772 | — | — | — | 170773 | |||||||||||||||||||||||||||||||||||
| Issuance of common stock under the 2025 Equity Distribution Agreement, net of offering costs | 6499935 | 1 | 78722 | — | — | — | 78723 | |||||||||||||||||||||||||||||||||||
| Vayu Acquisition | 1494906 | — | 37636 | — | — | — | 37636 | |||||||||||||||||||||||||||||||||||
| Short-swing profit disgorgement | — | — | 48 | — | — | — | 48 | |||||||||||||||||||||||||||||||||||
| Vested restricted stock units | 2437895 | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
| Exercise of warrants | 2315799 | — | 11431 | — | — | — | 11431 | |||||||||||||||||||||||||||||||||||
| Exercise of options | 237323 | — | 423 | — | — | — | 423 | |||||||||||||||||||||||||||||||||||
| Stock-based compensation | — | — | 21252 | — | — | — | 21252 | |||||||||||||||||||||||||||||||||||
| Other comprehensive income (loss) | — | — | — | — | 138 | — | 138 | |||||||||||||||||||||||||||||||||||
| Net loss | — | — | — | — | — | -101361 | -101361 | |||||||||||||||||||||||||||||||||||
| Balances at December 31, 2025 | 74734949 | 7 | 559485 | $— | 138 | -208886 | 350744 |
cash flows-1
| Consolidated Statements of Cash Flows | |||||||||
| Year Ended December 31, | |||||||||
| 2025 | 2024 | ||||||||
| Cash flows from operating activities: | |||||||||
| Net loss | -101361 | -39191 | |||||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||||||
| Stock-based compensation | 21252 | 14555 | |||||||
| Depreciation & amortization | 8213 | 310 | |||||||
| Deferred income taxes | -4702 | — | |||||||
| Accretion of discount on available-for-sale securities | -1073 | — | |||||||
| Amortization of debt discount | — | 1678 | |||||||
| Change in fair value of derivative liability | — | 222 | |||||||
| Changes in operating assets and liabilities, net of effects of businesses acquired: | |||||||||
| Accounts receivable, net | -697 | -84 | |||||||
| Inventory | — | 465 | |||||||
| Prepaid expenses | -4634 | -720 | |||||||
| Other receivables | -498 | -192 | |||||||
| Accounts payable | -2017 | 872 | |||||||
| Accrued liabilities | 6707 | 477 | |||||||
| Deferred revenue | -18 | 20 | |||||||
| Operating lease liabilities | -1413 | 46 | |||||||
| Net cash used in operating activities | -80241 | -21542 | |||||||
| Cash flows from investing activities: | |||||||||
| Purchases of marketable securities | -203752 | — | |||||||
| Proceeds from maturities and sales of marketable securities | 51500 | — | |||||||
| Purchases of property and equipment | -37334 | -10252 | |||||||
| Acquisitions, net of cash acquired | -7502 | — | |||||||
| Security deposits | -506 | -66 | |||||||
| Capitalized implementation costs | -405 | — | |||||||
| Net cash used in investing activities | -197999 | -10318 | |||||||
| Cash flows from financing activities: | |||||||||
| Proceeds from issuance of common, net of offering costs | 170773 | 35849 | |||||||
| Proceeds from issuance of common stock under the 2025 Equity Distribution Agreement, net of offering costs | 78723 | 77596 | |||||||
| Proceeds from exercise of warrants | 11431 | 22449 | |||||||
| Proceeds from exercise of options | 423 | 367 | |||||||
| Repayments of financing lease liability | -186 | -1782 | |||||||
| Proceeds from short-swing profit disgorgement | 48 | — | |||||||
| Proceeds from issuance of pre-funded warrants to purchase common stock in connection with private placement, net of issuance costs | — | 17116 | |||||||
| Proceeds from convertible notes payable, net of offering costs | — | 4845 | |||||||
| Repayments of note payable | — | -1250 | |||||||
| Repayment of note payable, related party | — | -70 | |||||||
| Net cash provided by financing activities | 261212 | 155120 | |||||||
| Effect of exchange rate changes on cash and cash equivalents | 1 | — | |||||||
| Net change in cash and cash equivalents | -17028 | 123260 | |||||||
| Cash and cash equivalents at beginning of year | 123266 | 7 | |||||||
| Cash and cash equivalents at end of year | 106239 | 123266 | |||||||
| Supplemental disclosure of cash flow information: | |||||||||
| Cash paid for interest | 224 | 203 | |||||||
| Cash paid for income taxes | $— | $— | |||||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||||||
| Operating lease right-of-use assets obtained for lease obligations | 4818 | 1578 | |||||||
| Purchases of property and equipment, accrued but not paid | 1723 | 1972 | |||||||
| Conversion of convertible notes and derivative into common stock | $— | 6804 |
net loss per share
| Net Loss per Share | |||||||||
| December 31, | |||||||||
| 2025 | 2024 | ||||||||
| Common stock warrants | 5079294 | 3340011 | |||||||
| Stock options | 826539 | 1022291 | |||||||
| Unvested restricted stock awards subject to recourse and nonrecourse loans | 46833 | 108008 | |||||||
| Unvested restricted stock units | 7217790 | 5362326 | |||||||
| Total potentially dilutive shares | 13170456 | 9832636 |
3 revenue
| 3. REVENUE | |||||||||
| Year Ended December 31, | |||||||||
| 2025 | 2024 | ||||||||
| Fleet services | 1622 | 627 | |||||||
| Software services | 1029 | 1186 | |||||||
| Total revenue | 2651 | 1813 |
notes to the consolidated
| Notes to the Consolidated Financial Statements | |||
| April 1, 2025 | |||
| Cash consideration paid | 5170 | ||
| Escrow amount | 575 | ||
| Purchase price | 5745 | ||
| Assets acquired: | |||
| Cash and cash equivalents | 111 | ||
| Other current assets | 73 | ||
| Other assets | 17 | ||
| Intangible assets, net | 1370 | ||
| Total identifiable assets acquired | 1571 | ||
| Liabilities assumed: | |||
| Current liabilities | -153 | ||
| Total identifiable liabilities assumed | -153 | ||
| Fair value of identifiable assets, net of identifiable liabilities assumed | 1418 | ||
| Goodwill | 4327 |
notes to the consolidated -1
| Weighted Average Useful Life | April 1, 2025 | ||||||||
| Developed technology | 15 | 980 | |||||||
| Customer relationships | 25 | 255 | |||||||
| Trade names | 10 | 135 | |||||||
| Total intangible assets | 16 | 1370 |
notes to the consolidated -2
| Notes to the Consolidated Financial Statements | |||||||||||||||
| Shares | Per Share | Total Consideration (in thousands) | |||||||||||||
| Cash paid for outstanding shares of Vayu common and preferred stock | 1875 | ||||||||||||||
| Net working capital adjustment | 310 | ||||||||||||||
| Company common shares issuable to Vayu common and preferred stockholders | 1539906 | 9.71 | 14952 | ||||||||||||
| Company warrants issued to Vayu SAFE holder, Khosla Ventures | 4000000 | 5.41 | 21640 | ||||||||||||
| Replacement equity awards attributable to pre-combination service | — | — | 734 | ||||||||||||
| Total purchase price consideration | 39511 |
notes to the consolidated -3
| Notes to the Consolidated Financial Statements | |||
| August 15, 2025 | |||
| Total purchase price consideration | 39511 | ||
| Assets acquired: | |||
| Cash and cash equivalents | 6 | ||
| Other current assets | 57 | ||
| Intangible assets | 32439 | ||
| Total identifiable assets acquired | 32502 | ||
| Liabilities assumed: | |||
| Accounts payable | -366 | ||
| Other current liabilities | -44 | ||
| Deferred tax liability | -3784 | ||
| Total identifiable liabilities assumed | -4194 | ||
| Fair value of identifiable assets, net of identifiable liabilities assumed | 28308 | ||
| Goodwill | 11203 |
5 goodwill and intangible
| 5. GOODWILL AND INTANGIBLE ASSETS, NET | |||
| Total | |||
| Balance as of December 31, 2024 | $— | ||
| Acquisitions | 15530 | ||
| Balance as of December 31, 2025 | 15530 |
notes to the consolidated -4
| Notes to the Consolidated Financial Statements | |||||||||||||||||||||
| Weighted-Average Remaining Useful Life (in years) | Gross Carrying Value | Accumulated Amortization | Net Carrying Value | ||||||||||||||||||
| Developed technology | 4.9 | 33419 | -2479 | 30940 | |||||||||||||||||
| Customer relationships | 24.3 | 255 | -7 | 248 | |||||||||||||||||
| Trade names | 9.3 | 135 | -10 | 125 | |||||||||||||||||
| Balance as of December 31, 2025 | 33809 | -2496 | 31313 |
notes to the consolidated -5
| Year Ending December 31, | Amortization Expense | ||
| 2026 | 6577 | ||
| 2027 | 6577 | ||
| 2028 | 6577 | ||
| 2029 | 6577 | ||
| 2030 | 4144 | ||
| Thereafter | 861 | ||
| Total estimated future amortization expense | 31313 |
6 fair value measurements
| 6. FAIR VALUE MEASUREMENTS | |||||||||||||||||||||
| Fair Value Measurements as of December 31, 2025: |
|||||||||||||||||||||
| Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||
| Cash equivalents | |||||||||||||||||||||
| Money market funds | 86714 | $— | $— | 86714 | |||||||||||||||||
| Commercial paper | — | 3995 | — | 3995 | |||||||||||||||||
| Short-term marketable securities | |||||||||||||||||||||
| Certificates of deposit | — | 40182 | — | 40182 | |||||||||||||||||
| Commercial paper | — | 35814 | — | 35814 | |||||||||||||||||
| Corporate notes/bonds | — | 47928 | — | 47928 | |||||||||||||||||
| U.S. Government agencies | — | 1251 | — | 1251 | |||||||||||||||||
| U.S. Treasury securities | — | 1995 | — | 1995 | |||||||||||||||||
| Long-term marketable securities | |||||||||||||||||||||
| Corporate notes/bonds | — | 20341 | — | 20341 | |||||||||||||||||
| U.S. Government agencies | — | 6003 | — | 6003 | |||||||||||||||||
| Total | 86714 | 157509 | $— | 244223 |
7 marketable securities
| 7. MARKETABLE SECURITIES | |||||||||||||||||||||
| December 31, 2025 | |||||||||||||||||||||
| Cost or Amortized Cost | Unrealized | Estimated Fair Value | |||||||||||||||||||
| Gains | Losses | ||||||||||||||||||||
| Cash equivalents | |||||||||||||||||||||
| Money market funds | 86714 | $— | $— | 86714 | |||||||||||||||||
| Commercial paper | 3995 | — | — | 3995 | |||||||||||||||||
| Short-term marketable securities | |||||||||||||||||||||
| Certificates of deposit | 40001 | 181 | — | 40182 | |||||||||||||||||
| Commercial paper | 35814 | — | — | 35814 | |||||||||||||||||
| Corporate notes/bonds | 47912 | 16 | — | 47928 | |||||||||||||||||
| U.S. Government agencies | 1251 | — | — | 1251 | |||||||||||||||||
| U.S. Treasury securities | 1994 | 1 | — | 1995 | |||||||||||||||||
| Long-term marketable securities | |||||||||||||||||||||
| Corporate notes/bonds | 20348 | — | -7 | 20341 | |||||||||||||||||
| U.S. Government agencies | 6005 | — | -2 | 6003 | |||||||||||||||||
| Total | 244034 | 198 | -9 | 244223 |
8 property and equipment net
| 8. PROPERTY AND EQUIPMENT, NET | |||||||||
| December 31, | |||||||||
| 2025 | 2024 | ||||||||
| Robot assets | 47221 | 4610 | |||||||
| Construction in progress | 3357 | 7826 | |||||||
| Tooling | 2111 | 1799 | |||||||
| Leasehold improvement | 414 | — | |||||||
| Office equipment | 375 | 332 | |||||||
| Total | 53478 | 14567 | |||||||
| Less: Accumulated depreciation | -6465 | -2604 | |||||||
| Property and equipment, net | 47013 | 11963 |
restricted stock awards rsas
| Restricted Stock Awards (RSAs) | |||||||||
| Restricted Stock Awards | |||||||||
| Number of Shares | Weighted Average Grant Date Fair Value | ||||||||
| Nonvested as of December 31, 2024 | 996799 | 0.38 | |||||||
| Granted | — | — | |||||||
| Vested | -663964 | 0.01 | |||||||
| Forfeited | -47782 | 0.48 | |||||||
| Nonvested as of December 31, 2025 | 285053 | 0.08 |
restricted stock units rsus
| Restricted Stock Units (RSUs) | |||||||||
| Restricted Stock Units | |||||||||
| Number of Shares | Weighted Average Grant Date Fair Value | ||||||||
| Nonvested as of December 31, 2024 | 5362326 | 7.49 | |||||||
| Granted | 4613157 | 10.67 | |||||||
| Vested | -2437895 | 7.21 | |||||||
| Forfeited | -319798 | 9.55 | |||||||
| Nonvested as of December 31, 2025 | 7217790 | 9.14 |
performancebased restricte
| Performance-Based Restricted Stock Units | |||||||||
| Number of Shares | Weighted Average Grant Date Fair Value | ||||||||
| Nonvested as of December 31, 2024 | — | $— | |||||||
| Granted | 1440001 | 9.71 | |||||||
| Nonvested as of December 31, 2025 | 1440001 | 9.71 |
stock options
| Stock Options | |||||||||||||||
| Options | Weighted Average Exercise Price | Intrinsic Value (in thousands) | |||||||||||||
| Outstanding as of December 31, 2023 | 1515386 | 0.61 | 5112 | ||||||||||||
| Granted | 110374 | 4.05 | |||||||||||||
| Exercised | -511787 | 0.71 | 6544 | ||||||||||||
| Forfeited | -91682 | 0.77 | |||||||||||||
| Outstanding as of December 31, 2024 | 1022291 | 0.94 | 12843 | ||||||||||||
| Granted | 89438 | 5.49 | |||||||||||||
| Exercised | -237323 | 1.05 | 2463 | ||||||||||||
| Forfeited | -47867 | 1.98 | |||||||||||||
| Outstanding as of December 31, 2025 | 826539 | 1.01 | 8573 | ||||||||||||
| Exercisable as of December 31, 2025 | 682717 | 1.08 | 7087 | ||||||||||||
| Exercisable and expected to vest at December 31, 2025 | 826539 | 1.01 | 8573 |
warrants
| Warrants | |||||||||
| Warrants | Weighted Average Exercise Price |
||||||||
| Outstanding as of December 31, 2024 | 3340011 | 6.56 | |||||||
| Granted | 4000000 | 10.36 | |||||||
| Exercised | -2260717 | 5.12 | |||||||
| Forfeited | — | — | |||||||
| Outstanding as of December 31, 2025 | 5079294 | 10.18 | |||||||
| Exercisable as of December 31, 2025 | 5079294 | 10.18 |
11 stockbased compensation
| 11. STOCK-BASED COMPENSATION | |||||||||
| Year Ended December 31, | |||||||||
| 2025 | 2024 | ||||||||
| General and administrative | 10416 | 2834 | |||||||
| Research and development | 9829 | 11492 | |||||||
| Operations | 661 | 146 | |||||||
| Sales and marketing | 346 | 83 | |||||||
| Total stock-based compensation expense | 21252 | 14555 |
12 income taxes
| 12. INCOME TAXES | |||
| Year Ended December 31, 2025 | |||
| Domestic | -103169 | ||
| Foreign | -1848 | ||
| Total net loss before income taxes | -105017 | ||
| Note: Amounts for the year ended December, 31, 2024 were immaterial. |
12 income taxes-1
| Year Ended December 31, 2025 | |||
| Current: | |||
| Federal | 568 | ||
| State | 478 | ||
| Foreign | — | ||
| Total current tax expense | 1046 | ||
| Deferred: | |||
| Federal | -4175 | ||
| State | -443 | ||
| Foreign | -84 | ||
| Total deferred tax benefit | -4702 | ||
| Total income tax benefit | -3656 | ||
| Note: Amounts for the year ended December, 31, 2024 were immaterial. |
notes to the consolidated -6
| Notes to the Consolidated Financial Statements | |||||||||
| Year Ended December 31, 2025 | |||||||||
| Amount | Percent | ||||||||
| Income tax benefit at U.S. federal statutory rate | -22054 | 21.0% | |||||||
| State and local income taxes, net of federal income tax effect (1) | -436 | 0.4% | |||||||
| Foreign tax effects | 305 | ( 0.3 )% | |||||||
| Tax credits | -800 | 0.8% | |||||||
| Changes in valuation allowances | 18641 | ( 17.8 )% | |||||||
| Non taxable or nondeductible items | |||||||||
| Stock-based compensation | -2867 | 2.7% | |||||||
| Section 162(m) executive compensation limitation | 2120 | ( 2.0 )% | |||||||
| Other | 85 | ( 0.1 )% | |||||||
| Changes in unrecognized tax benefits | 1039 | ( 1.0 )% | |||||||
| Other adjustments | 311 | ( 0.3 )% | |||||||
| Income tax benefit at effective tax rate | -3656 | 3.5% | |||||||
| (1) In 2025, the state that contributed to the majority (greater than 50%) of the tax effect in this category is California. | |||||||||
| Note: Amounts for the year ended December, 31, 2024 were immaterial. |
notes to the consolidated -7
| Notes to the Consolidated Financial Statements | |||||||||
| December 31, | |||||||||
| 2025 | 2024 | ||||||||
| Net operating loss and credit carryforwards | 57660 | 15004 | |||||||
| Capitalized research and development costs | 5092 | 5988 | |||||||
| Stock-based compensation | 1631 | — | |||||||
| Lease obligations | 1114 | — | |||||||
| Other deferred tax assets | 34 | 411 | |||||||
| Gross Deferred tax assets | 65531 | 21403 | |||||||
| Less: Valuation Allowance | -55620 | -21403 | |||||||
| Total deferred tax assets | 9911 | $— | |||||||
| Deferred tax liabilities: | |||||||||
| Intangible assets | -7764 | $— | |||||||
| Operating lease right-of-use assets | -1141 | — | |||||||
| Property and equipment | -138 | — | |||||||
| Total deferred tax liabilities | -9043 | — | |||||||
| Net deferred tax asset | 868 | $— |
notes to the consolidated -8
| Notes to the Consolidated Financial Statements | |||
| December 31, 2025 | |||
| Balance at beginning of year | $— | ||
| Additions for tax positions in prior year | 789 | ||
| Additions for tax positions in current year | 250 | ||
| Settlements | — | ||
| Release due to statute expirations | — | ||
| Balance at end of year | 1039 | ||
| Note: Amounts for the year ended December, 31, 2024 were immaterial. |
13 commitments and conting
| 13. COMMITMENTS AND CONTINGENCIES | ||||||||||||
| Financial Statement Line Item | Year Ended December 31, |
|||||||||||
| 2025 | 2024 | |||||||||||
| Operations | 1918 | 719 | ||||||||||
| Research and development | 80 | 242 | ||||||||||
| General and administrative | 68 | 56 | ||||||||||
| Sales and marketing | 8 | — | ||||||||||
| Total lease costs | 2074 | 1017 |
13 commitments and conting-1
| Year Ended December 31, |
|||||||||
| 2025 | 2024 | ||||||||
| Operating cash flows paid for operating leases | 1518 | 593 | |||||||
| Right-of-use assets obtained in exchange for operating lease obligations | 4818 | 1578 |
notes to the consolidated -9
| Notes to the Consolidated Financial Statements | |||||||||
| December 31, | |||||||||
| 2025 | 2024 | ||||||||
| Weighted-average remaining lease term (in years) | 3.42 | 2.65 | |||||||
| Weighted-average discount rate | 7.39% | 7.24% |
notes to the consolidated -10
| Year Ending December 31, | Amount | |||||
| 2026 | 2087 | |||||
| 2027 | 1805 | |||||
| 2028 | 872 | |||||
| 2029 | 577 | |||||
| 2030 | 441 | |||||
| Thereafter | 136 | |||||
| Total undiscounted future cash flows | 5918 | |||||
| Less: imputed interest | -664 | |||||
| Total minimum payments | 5254 |
exhibit index
| EXHIBIT INDEX | ||||||
| Exhibit No. | Description | |||||
| 3.1 | Amended and Restated Certificate of Incorporation, filed with the Secretary of State of the State of Delaware on July 31, 2023 (incorporated by reference to Exhibit 3.2 to the Current Report on Form 8-K filed with the SEC on August 4, 2023). | |||||
| 3.2 | Amended and Restated Bylaws (incorporated by reference to Exhibit 3.3 to the Current Report on Form 8-K filed with the SEC on August 4, 2023). | |||||
| 4.1 | Form of August Exchange Warrant (incorporated by reference to Exhibit 10.5 to the Current Report on Form 8-K filed with the SEC on August 28, 2024). | |||||
| 4.2 | Common Stock Purchase Warrant, dated as of August 15, 2025 (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed with the SEC on August 1 8, 202 5 ) . | |||||
| 4.3 | Description of Securities (incorporated by reference to Exhibit 4.8 to the Annual Report on Form 10-K filed with the SEC on February 29, 2024) . | |||||
| 10.1+§ | Offer Letter, dated as of March 1, 2021, by and between Touraj Parang and the Company (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the SEC on August 4, 2023). | |||||
| 10.2+§ | Offer Letter, dated March 24, 2024, by and between Brian Read and Serve Operating Co. (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on April 9, 2024). | |||||
| 10.3 | Form of Pre-Merger Indemnification Agreement (incorporated by reference to Exhibit 10.21 to the Current Report on Form 8-K filed with the SEC on August 4, 2023). | |||||
| 10.4+ | 2021 Stock Plan and form of award agreements (incorporated by reference to Exhibit 10.24 to the Current Report on Form 8-K filed with the SEC on August 4, 2023). | |||||
| 10.5+ | 2023 Equity Incentive Plan and form of award agreements (incorporated by reference to Exhibit 10.29 to the Company ’ s report on Form 10-K filed with the SEC on February 29, 2024). | |||||
| 10.6+ | Amendment to Serve Robotics Inc. ’ s 2023 Equity Incentive Plan (incorporated by reference to the Company ’ s Form DEF14A filed with the SEC on June 7, 2024). | |||||
| 10.7+ | Amendment to Serve Robotics Inc. ’ s 2023 Equity Incentive Plan (incorporated by reference to the Company ’ s Form DEF14A filed with the SEC on April 25, 2025). | |||||
| 10.8+ | Vayu Robotics, Inc. 2022 Equity Incentive Plan (incorporated by reference to Exhibit 99.1 to the Registration Statement on Form S-8 filed with the SEC on August 25, 2025). | |||||
| 10.9+ | Vayu Robotics, Inc. 2025 Equity Incentive Plan (incorporated by reference to Exhibit 99.2 to the Registration Statement on Form S-8 filed with the SEC on August 25, 2025). | |||||
| 10.10+ | Serve Robotics Inc. Amended and Restated Outside Director Compensation Policy ( incorporated by reference to Exhibit 10.2 5 to the Annual Report on Form 10 -K filed with the SEC on March 6 , 2025) . | |||||
| 10.11 | Form of August Registration Rights Agreement (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed with the SEC on August 28, 2024). | |||||
| 10.12 | Form of August Securities Purchase Agreement (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the SEC on August 28, 2024). | |||||
| 10.13 | Form of Securities Purchase Agreement, by and among the Company and the Purchaser (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the SEC on January 7, 2025 ). | |||||
| 10.14 | Placement Agency Agreement, dated January 7, 2025, by and between Serve Robotics Inc. and Northland Securities, Inc. (incorporated by reference to Exhibit 10. 2 to the Current Report on Form 8-K filed with the SEC on January 7, 2025) . | |||||
| 10.15 | Form of Securities Purchase Agreement, by and among the Company and the Purchasers (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the SEC on October 10 , 2025). | |||||
| 10.16 | Placement Agency Agreement, dated October 10, 2025, by and between Serve Robotics Inc. and Northland Securities, Inc. (incorporated by reference to Exhibit 10. 2 to the Current Report on Form 8-K filed with the SEC on October 10, 2025). | |||||
| 16.1 | L etter from dbbmckennon as to the change in cert ifying accountant, dated March 6, 2025 ( incorporated by reference to Exhibit 16.1 to the Current Report on Form 8-K filed with the SEC on March 6, 2025 ). | |||||
| 19.1* | Serve Robotics Inc. Amended and Restated Insider Trading Policy. |
exhibit index-1
| 21.1* | Subsidiaries of the Registrant . | |||||
| 23.1* | Consent of PricewaterhouseCoopers LLP. | |||||
| 23.2* | Consent of dbbmckennon. | |||||
| 31.1* | Certification of Principal Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |||||
| 31.2* | Certification of Principal Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |||||
| 32.1** | Certification of Principal Executive Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) | |||||
| 32.2** | Certification of Principal Financial Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) | |||||
| 97.1 | Serve Robotics Inc. Compensation Recovery Policy (incorporated by reference to Exhibit 97.1 to the Annual Report on Form 10-K filed with the SEC on February 29, 2024) . | |||||
| 101.INS | Inline XBRL Instance Document. | |||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document. | |||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | |||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. | |||||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. | |||||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. | |||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |
certification of principal
| Certification of Principal Executive Officer Pursuant to Exchange Act Rule 13a-14(a)/15d-14(a) as Adopted | |||
| Date: March 12, 2026 | /s/ Ali Kashani | ||
| Ali Kashani | |||
| Chief Executive Officer | |||
| (Principal Executive Officer) |
certification of principal-1
| Certification of Principal Financial Officer Pursuant to Exchange Act Rule 13a-14(a)/15d-14(a) as Adopted | |||
| Date: March 12, 2026 | /s/ Brian Read | ||
| Brian Read | |||
| Chief Financial Officer | |||
| (Principal Financial and Accounting Officer) |
certification of principal-2
| Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant | |||
| Date: March 12, 2026 | /s/ Ali Kashani | ||
| Ali Kashani | |||
| Chief Executive Officer | |||
| (Principal Executive Officer) |
certification of principal-3
| Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant | |||
| Date: March 12, 2026 | /s/ Brian Read | ||
| Brian Read | |||
| Chief Financial Officer | |||
| (Principal Financial and Accounting Officer) |